Literature DB >> 22732734

Dendritic cells and their role in tumor immunosurveillance.

Marius Strioga1, Virgil Schijns, Daniel J Powell, Vita Pasukoniene, Neringa Dobrovolskiene, Jaroslav Michalek.   

Abstract

Dendritic cells (DCs) comprise a heterogeneous population of cells that play a key role in initiating, directing and regulating adaptive immune responses, including those critically involved in tumor immunosurveillance. As a riposte to the central role of DCs in the generation of antitumor immune responses, tumors have developed various mechanisms which impair the immunostimulatory functions of DCs or even instruct them to actively contribute to tumor growth and progression. In the first part of this review we discuss general aspects of DC biology, including their origin, subtypes, immature and mature states, and functional plasticity which ensures a delicate balance between active immune response and immune tolerance. In the second part of the review we discuss the complex interactions between DCs and the tumor microenvironment, and point out the challenges faced by DCs during the recognition of tumor Ags. We also discuss the role of DCs in tumor angiogenesis and vasculogenesis.

Entities:  

Mesh:

Year:  2012        PMID: 22732734     DOI: 10.1177/1753425912449549

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  20 in total

1.  Uncovering the underlying mechanism of cancer tumorigenesis and development under an immune microenvironment from global quantification of the landscape.

Authors:  Li Wenbo; Jin Wang
Journal:  J R Soc Interface       Date:  2017-06       Impact factor: 4.118

Review 2.  Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation.

Authors:  Ghazal Nabil; Ketki Bhise; Samaresh Sau; Mohamed Atef; Hossny A El-Banna; Arun K Iyer
Journal:  Drug Discov Today       Date:  2018-08-16       Impact factor: 7.851

Review 3.  The subtle interplay between gamma delta T lymphocytes and dendritic cells: is there a role for a therapeutic cancer vaccine in the era of combinatorial strategies?

Authors:  Domenico Galati; Serena Zanotta; Marialuisa Bocchino; Rosaria De Filippi; Antonio Pinto
Journal:  Cancer Immunol Immunother       Date:  2021-01-01       Impact factor: 6.968

4.  Repulsive guidance molecule a blockade exerts the immunoregulatory function in DCs stimulated with ABP and LPS.

Authors:  Xuxu Xu; Yan Gao; Zhiyong Zhai; Shuo Zhang; Fengping Shan; Juan Feng
Journal:  Hum Vaccin Immunother       Date:  2016-03-17       Impact factor: 3.452

Review 5.  Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.

Authors:  Samaresh Sau; Hashem O Alsaab; Ketki Bhise; Rami Alzhrani; Ghazal Nabil; Arun K Iyer
Journal:  J Control Release       Date:  2018-01-31       Impact factor: 9.776

6.  Ovarian Cancer: Therapeutic Strategies to Overcome Immune Suppression.

Authors:  Maureen L Drakes; Patrick J Stiff
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Post-operative unadjuvanted therapeutic xenovaccination with chicken whole embryo vaccine suppresses distant micrometastases and prolongs survival in a murine Lewis lung carcinoma model.

Authors:  Jan Aleksander Kraśko; Karolina Žilionytė; Adas Darinskas; Neringa Dobrovolskienė; Agata Mlynska; Svetlana Riabceva; Iosif Zalutsky; Marina Derevyanko; Vladimir Kulchitsky; Olga Karaman; Natalia Fedosova; Tatiana Vasyliyvna Symchych; Gennady Didenko; Vasyl Chekhun; Marius Strioga; Vita Pašukonienė
Journal:  Oncol Lett       Date:  2018-02-05       Impact factor: 2.967

8.  TNP-470 skews DC differentiation to Th1-stimulatory phenotypes and can serve as a novel adjuvant in a cancer vaccine.

Authors:  Derek Hoi-Hang Ho; Roger Hoi-Fung Wong
Journal:  Blood Adv       Date:  2018-07-24

9.  Silenced suppressor of cytokine signaling 1 (SOCS1) enhances the maturation and antifungal immunity of dendritic cells in response to Candida albicans in vitro.

Authors:  Dongmei Shi; Dongmei Li; Qingxin Yin; Ying Qiu; Hongxia Yan; Yongnian Shen; Guixia Lu; Weida Liu
Journal:  Immunol Res       Date:  2015-03       Impact factor: 2.829

Review 10.  Annexin A2: its molecular regulation and cellular expression in cancer development.

Authors:  Chi-Yun Wang; Chiou-Feng Lin
Journal:  Dis Markers       Date:  2014-01-23       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.